Navigation Links
Quality Standards Established for Competition to Identify Best Researchers in the US
Date:4/17/2012

LONDON, April 17, 2012 /PRNewswire/ --

Senior clinical executives from top pharmaceutical companies, including AstraZeneca, Sanofi, Shire and GSK, met recently at the US offices of Shire Pharmaceuticals to agree quality standards and define competencies for a global competition to recognise and encourage talented researchers in North and South America.

The US Clinical Researcher of the Year competition (http://www.usclinicalresearcher.com) provides professionals working within the clinical research fraternity an opportunity for personal development through a series of peer-mediated, competency-based exercises. It is partnered with and sponsored by the ACRP.

"There are very few opportunities for professionals to benchmark their skills within a protected environment, where the quality standards are established and judged by senior industry peers," notes Sean Morgan-Jones of organizers PharmaTimes. "The aims of the competition are three-fold. To provide a development opportunity for ambitious research professionals, to help organizations benchmark with their peers, and to deliver industry insights and learning."

Themes identified by the competition's Executive Steering Committee for the 2012 competition include risk-based monitoring and technology as a facilitator for patient recruitment. The committee's first task was to agree quality standards for the first phase of the competition, an online multiple-choice questionnaire based on ICH/GCP/FDA regulatory guidelines and ratified by lead examiners from ACRP. Susan Romberg, vice president of clinical operations for the Americas at competition sponsors PRA, is leading a sub-committee to develop the case study used in the second screening stages.

This year the qualifying score has been raised to 80%.

The finals and awards are on November 8, 2012, at the Executive Briefing Centre of competition sponsors and hosts, SAS, in Cary, North Carolina.

Up to 10 finalists will compete head to head for six titles, Study Nurse (working at the investigator site), New CRA (less than four years' experience), Experienced CRA (more than four years' experience), Trial Manager (working with a sponsor company), Project Manager (working within a CRO) and Clinical Research Team.

Jo West, from PRA and winner of the CRA category last year, commented: "This is a first class competition. I was challenged and exhilarated from the time of entering through to the awards evening. I would encourage all individuals to enter the competition to reinforce and build their confidence and knowledge to further their careers."

Entry is open for the 2012 US Clinical Researcher of the Year Competition. Go to http://www.usclinicalresearcher.com or email sean@pharmatimes.com or call +44-208-8788566



'/>"/>
SOURCE Pharma Times
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
2. AMPAC Fine Chemicals Continues to Invest in Quality Systems
3. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
4. New Resource Provides Herb Industry With Sources of Quality Specifications
5. Establishing the Correct QbD Strategies and Tools Early in the Development Process is Key to Ensuring we Have Robust Quality Products Downstream
6. Controlling silicon evaporation allows scientists to boost graphene quality
7. Clinical Integration Enables Leading Health Systems to Deliver Higher Quality, Cost-Effective Care
8. New Study Finds Cord Blood-derived Stem Cell Treatments Improve Ataxia Patients Functionality and Quality of Life
9. PrimeraDx Names Fayyaz Memon Vice President of Regulatory Affairs and Quality Assurance
10. Elsevier Strikes Exclusive eLearning Partnership with The Quality Group
11. ACO Proposed Rule: Nine out of Ten Quality Measures Mirror Other Quality Reporting Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma A/S ... innovative TransCon technology to address significant unmet medical ... for the full year ended December 31, 2016. ... for our company as we broadened our pipeline ... integrated rare disease company with an initial focus ...
(Date:3/22/2017)... 22, 2017   iSpecimen ®, the ... Doctors Pathology Service (DPS), a full-service anatomic pathology ... the United States , has joined a program ... Network (DHIN) to make human biospecimens and associated ... novel program, announced in 2015 as a collaboration between ...
(Date:3/22/2017)... 2017   Boston Biomedical , an industry leader ... target cancer stemness pathways, today announced its Board of ... Chief Executive Officer, effective April 24, 2017. ... , M.D., FACP, who has led Boston Biomedical since ... leadership, Boston Biomedical has grown from a "garage startup" ...
(Date:3/22/2017)... Yorba Linda, Ca (PRWEB) , ... March 21, ... ... immunogenicity, and clearance of biologics. To acquire information on the desired increase and/or ... in the biopharmaceutical industry for rapid N-glycosylation profiling of therapeutic antibodies. , ...
Breaking Biology Technology:
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
Breaking Biology News(10 mins):